Stock Price Quote

AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE1499.20-11.1 (-0.73 %)
PREV CLOSE ( ) 1510.30
OPEN PRICE ( ) 1510.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6694
TODAY'S LOW / HIGH ( )1482.90 1524.00
52 WK LOW / HIGH ( )840 1578.1
NSE1498.30-13.95 (-0.92 %)
PREV CLOSE( ) 1512.25
OPEN PRICE ( ) 1520.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1498.30 (30)
VOLUME 125713
TODAY'S LOW / HIGH( ) 1482.00 1525.00
52 WK LOW / HIGH ( )825 1580
BSE NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 31-12 1979
Management Info
Mannalal B Agrawal - Chairman Yogesh M Agrawal - Managing Director
Registered Office

Address Ajanta House,Charkop ,Kandivali (W),
Mumbai,
Maharashtra-400067

Phone 91-22-66061000

Email info@ajantapharma.com

Website www.ajantapharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

21Jan Ajanta Pharma informs about newspaper
Pursuant to Regulation 47 of the Listing Regulations, Ajanta Pharma has..
06Nov Ajanta Pharma reports 7% fall in Q2 co
Ajanta Pharma has reported results for second quarter ended September 30..
06Nov Ajanta Pharma advances despite reporti
Ajanta Pharma is currently trading at Rs. 1013.85, up by 11.45 points or..
11Oct Ajanta Pharma informs about company up
As per the requirement of Regulation 7(3) of the SEBI (Listing Obligatio..
13Aug Ajanta Pharma informs about issuance o
Ajanta Pharma has informed about issue of Duplicate Share Certificates u..
MORE

Financials

in Millions
QTR Mar 20 ANNUAL 20
Net Profit885.1000000000014411.3
Gross Profit 1296.2 6126.7
Operating Profit 1599.57169.8
Net Sales 5606.821964.2
MORE

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  7981.35 (5.91%)
M.Cap ( in Cr)18381.55
Abbott India (BSE)
peergroup  16809.65 (2.17%)
M.Cap ( in Cr)35719.33
Procter&Gamble Healt (BSE)
peergroup  3952.50 (1.23%)
M.Cap ( in Cr)6560.91
Aarti Drugs (BSE)
peergroup  884.25 (3.85%)
M.Cap ( in Cr)2060.30
Ipca Laboratories (BSE)
peergroup  1620.25 (1.52%)
M.Cap ( in Cr)20472.20
MORE

Shareholding Pattern

MUTUAL FUNDS/UTI 9.25%
NON-INSTITUTION 9.21%
PROMOTERS 70.5%
GOVERNMENT 0.74%
FI/BANKS/INSURANCE 0.62%
FII 0%
MORE

Mf Holdings

MORE

About Ajanta Pharma Ltd.

Ajanta Pharma Ltd. was incorporated in the year 1979. Its today's share price is 1510.3. Its current market capitalisation stands at Rs 13082.21 Cr. In the latest quarter, company has reported Gross Sales of Rs. 17726.2 Cr and Total Income of Rs.18747.7 Cr. The company's management includes Anjana Grewal, Prabhakar Dalal, K H Viswanathan, Chandrakant M Khetan, Rajesh M Agrawal, Yogesh M Agrawal, Madhusudan B Agrawal, Mannalal B Agrawal.

It is listed on the BSE with a BSE Code of 532331 , NSE with an NSE Symbol of AJANTPHARM and ISIN of INE031B01049. It's Registered office is at Ajanta House,Charkop ,Kandivali (W)Mumbai-400067, Maharashtra. Their Registrars are ACC Ltd. It's auditors are BSR & Co LLP, Kapoor & Parekh Associates

download beyond app
About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang
Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Margin Funding Algo Trading
Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays
Derivatives Updates Market Report Overview
IPO IPO Issues Performance News & Analysis
Commodities Market Movers News & Commentary MCX / NCDEX Holidays
Mutual Funds About Nirmal Bang Wealth Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Annual Return 2018 Annual Return 2017 Mutual Fund Terms & Conditions Mutual Privacy Policy
Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research
Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap
Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI ScoresRMS Policy
Connect with Us
ATTENTION INVESTORS Depository IPO KYC
Inactive account treatmentNBSPL Policy of AMLNBEPL Policy of AMLNBCPL Policy of AMLNBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar UpdationNirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019
Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300
For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain.     |    

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X
AppleApp Store GooglePlay Store
AppleApp StoreGooglePlay Store
Support
Videos